AAAAAA

   
Results: 1-10 |
Results: 10
DOSE PROPORTIONALITY OF CISATRACURIUM
Authors: SCHMITH VD FIEDLERKELLY J PHILLIPS L GRASELA TH
Citation: Vd. Schmith et al., DOSE PROPORTIONALITY OF CISATRACURIUM, Journal of clinical pharmacology, 37(7), 1997, pp. 625-629
THE EFFECTS OF EPOPROSTENOL ON DRUG DISPOSITION .1. A PILOT-STUDY OF THE PHARMACOKINETICS OF DIGOXIN WITH AND WITHOUT EPOPROSTENOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: CARLTON LD PATTERSON JH MATTSON CN SCHMITH VD
Citation: Ld. Carlton et al., THE EFFECTS OF EPOPROSTENOL ON DRUG DISPOSITION .1. A PILOT-STUDY OF THE PHARMACOKINETICS OF DIGOXIN WITH AND WITHOUT EPOPROSTENOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of clinical pharmacology, 36(3), 1996, pp. 247-256
THE EFFECTS OF EPOPROSTENOL ON DRUG DISPOSITION .2. A PILOT-STUDY OF THE PHARMACOKINETICS OF FUROSEMIDE WITH AND WITHOUT EPOPROSTENOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: CARLTON LD PATTERSON JH MATTSON CN SCHMITH VD
Citation: Ld. Carlton et al., THE EFFECTS OF EPOPROSTENOL ON DRUG DISPOSITION .2. A PILOT-STUDY OF THE PHARMACOKINETICS OF FUROSEMIDE WITH AND WITHOUT EPOPROSTENOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of clinical pharmacology, 36(3), 1996, pp. 257-264
PHARMACOKINETICS OF CISATRACURIUM IN PATIENTS RECEIVING NITROUS-OXIDEOPIOID BARBITURATE ANESTHESIA
Authors: LIEN CA SCHMITH VD BELMONT MR ABALOS A KISOR DF SAVARESE JJ
Citation: Ca. Lien et al., PHARMACOKINETICS OF CISATRACURIUM IN PATIENTS RECEIVING NITROUS-OXIDEOPIOID BARBITURATE ANESTHESIA, Anesthesiology, 84(2), 1996, pp. 300-308
IMPORTANCE OF THE ORGAN-INDEPENDENT ELIMINATION OF CISATRACURIUM
Authors: KISOR DF SCHMITH VD WARGIN WA LIEN CA ORNSTEIN E COOK DR
Citation: Df. Kisor et al., IMPORTANCE OF THE ORGAN-INDEPENDENT ELIMINATION OF CISATRACURIUM, Anesthesia and analgesia, 83(5), 1996, pp. 1065-1071
INTRAVENOUS EPOPROSTENOL SODIUM DOES NOT INCREASE HEPATIC-MICROSOMAL ENZYME-ACTIVITY IN RATS
Authors: CARLTON LD SCHMITH VD BROUWER KLR
Citation: Ld. Carlton et al., INTRAVENOUS EPOPROSTENOL SODIUM DOES NOT INCREASE HEPATIC-MICROSOMAL ENZYME-ACTIVITY IN RATS, Prostaglandins, 50(5-6), 1995, pp. 341-347
POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PWPD) OF 51W89 IN HEALTHY PEDIATRIC-PATIENTS
Authors: PHILLIPS L SCHMITH VD BRANDOM BW FIEDLERKELLY J GRASELA TH
Citation: L. Phillips et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PWPD) OF 51W89 IN HEALTHY PEDIATRIC-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213
POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PW PD) OF 51W89, A NEW NEUROMUSCULAR BLOCKING-AGENT/
Authors: SCHMITH VD FIEDLERKELLY J PHILLIPS L GRASELA TH
Citation: Vd. Schmith et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PW PD) OF 51W89, A NEW NEUROMUSCULAR BLOCKING-AGENT/, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213
EFFECT OF ADVANCED AGE ON THE PHARMACODYNAMICS OF DOXACURIUM - REPLY
Authors: SCHMITH VD FIEDLERKELLY J GRASELA TH
Citation: Vd. Schmith et al., EFFECT OF ADVANCED AGE ON THE PHARMACODYNAMICS OF DOXACURIUM - REPLY, Clinical pharmacology and therapeutics, 55(3), 1994, pp. 360-362
THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE STEREOISOMERS OF MIVACURIUM IN PATIENTS RECEIVING NITROUS OXIDE OPIOID/BARBITURATE ANESTHESIA/
Authors: LIEN CA SCHMITH VD EMBREE PB BELMONT MR WARGIN WA SAVARESE JJ
Citation: Ca. Lien et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE STEREOISOMERS OF MIVACURIUM IN PATIENTS RECEIVING NITROUS OXIDE OPIOID/BARBITURATE ANESTHESIA/, Anesthesiology, 80(6), 1994, pp. 1296-1302
Risultati: 1-10 |